FDG accumulation and tumor biology

Nuclear Medicine and Biology

Volumn 25, Issue 4, 1998, Pages 317-322

  Pauwels, E K J ^a,b   Ribeiro, M J ^b,c   Stoot, J H M B ^a   McCready, V R ^d   Bourguignon, M ^e   Maziere B ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DIF   (France)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

^e Off Protect Contre Rayon I   (France)

Author keywords

Fluorodeoxyglucose; Scintigraphy; Tumor biology

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; GLUCOSE TRANSPORTER; HEXOKINASE;

DRUG UPTAKE; GLYCOLYSIS; HYPOXIA; ISOTOPE LABELING; SHORT SURVEY; TUMOR CELL; TUMOR SCINTISCANNING; TUMOR SUPPRESSOR GENE;

FLUORODEOXYGLUCOSE F18; GLUCOSE; GLYCOLYSIS; HUMANS; MUTAGENESIS; NEOPLASMS; RADIOPHARMACEUTICALS;

EID: 0031971927     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00226-6     Document Type: Short Survey

References (54)

1. Appleman J. R., Lienhard G. E. Kinetics of the purified glucose transporter Direct measurement of the rates of interconversion of transporter conformers . Biochemistry. 28:1989;8221-8227.
2. Arora K. K., Fancuilli M., Pedersen P. L. Glucose phosphorylation in tumor cells Cloning, sequencing, and overexpression in active form of a full-length cDNA encoding a mitochondrial bindable form of hexokinase . J. Biol. Chem. 265:1990;6481-6488.
3. Baldwin S. A., Barros L. F., Griffith M. Trafficking of glucose transporters - signals and mechanisms. Biosci. Rep. 15:1995;419-426.
4. Bell G. I., Burant C. F., Takeda J., Gould G. W. Structure and function of mammalian facilitative sugar transporters. J. Biol. Chem. 268:1993;19161-19164.
5. Biersack H. J., Bender H., Ruhlmann J., Schomburg A., Grünwald F. FDG-PET in clinical oncology Review and evaluation of results of a private clinical PET center . Freeman L. M. Nuclear Medicine Annual. 1997;1-29 Lippincott-Raven Publishers, Philadelphia.
6. Birnbaum M. J., Haspel H. C., Rosen O. M. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science. 235:1987;1495-1497.
7. Bourne H. R., Sanders D. A., McCormick F. The GTPase superfamily A conserved switch for diverse cell functions . Nature. 348:1990;125-132.
8. Brock C. S., Meikle S. R., Price P. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology? Eur. J. Nucl. Med. 24:1997;691-705.
9. Bustamante E., Morris H. P., Pedersen P. L. Energy metabolism of tumor cells Requirement for a form of hexokinase with a propensity for mitochondrial binding . J. Biol. Chem. 256:1981;8699-8704.
10. Carruthers A. Facilitated diffusion of glucose. Physiol. Rev. 70:1990;1135-1175.
11. Cloherty E. K., Heard K. S., Carruthers A. Human erythrocyte sugar transport is incompatible with available carrier models. Biochemistry. 35:1996;10411-10421.
12. 18F]-FDG in oncology A clinical update . Nucl. Med. Biol. 23:1996;717-735.
13. Denissenko M. F., Pao A., Tang M., Pfeifer G. P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hot spots in p53. Science. 274:1996;430-432.
14. el-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
15. Fanciulli M., Paggi M. G., Btuno T., Delcarlo C., Bonetto F., Gentile F. P., Florida A. Glycolysis and growth rate in normal and in hexokinase transfected NIH 3T3 cells. Oncol. Res. 6:1994;405-409.
16. Fischman A. J., Alpert N. M. FDG-PET in oncology There's more to it than looking at pictures . J. Nucl. Med. 34:1993;6-11.
17. Flier J. S., Mueckler M. M., Usher P., Lodish H. F. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science. 235:1987;1492-1495.
18. Gallagher B. M., Fowler J. S., Gutterson N. I., MacGregor R. R., Wan C. N., Wolf A. P. Metabolic trapping as a principle of radiopharmaceutical design Some factors responsible for the biodistribution of [18-F] 2-deoxy-2-fluoro-D-glucose . J. Nucl. Med. 19:1978;1154-1161.
19. Glebov O. K., McKenzie K. E., White C. A., Sukumar S. Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res. 54:1994;3703-3709.
20. Haberkorn U., Straus L. G., Dimitrakopoulou A., Engenhart R., Oberdorfer F., Ostertag H., Romahn J., van Kaick G. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J. Nucl. Med. 32:1991;1485-1490.
21. Hamberg L. M., Hunter G. J., Alpert N. M., Choi N. C., Babich J. W., Fischman A. J. The dose uptake ratio as an index of glucose metabolism Useful parameter or oversimplification? J. Nucl. Med. 35:1994;1308-1312.
22. Hatanaka M. Transport of sugars in tumor cell membranes. Biochim. Biophys. Acta. 355:1974;77-104.
23. Hiraki Y., Rosen O. M., Birnbaum M. J. Growth factors rapidly induce expression of the glucose transporter gene. J. Biol. Chem. 263:1988;13655-13662.
24. Inukai K., Katagiri H., Takata K., Asano T., Anai M., Ishihara H., Nakazaki M., Kikuchi M., Yazaki Y., Oka Y. Characterization of rat GLUT5 and functional analysis of chimeric proteins of GLUT1 glucose transporter and GLUT5 fructose transporter. Endocrinology. 136:1995;4850-4857.
25. Karnik P. S., Kulkarni S., Liou X. P., Budd G. T., Bukowski R. M. Estrogen-receptor mutations in tamoxifen-resistant breast cancer. Cancer Res. 54:1994;349-353.
26. Kubota R., Yamada S., Kubota K., Ishiwata K., Tamahashi N., Ido T. Intramural distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissue studies by microautoradiography. J. Nucl. Med. 33:1992;1972-1980.
27. Martineau R., Kohlbacher M., Shaw S. N., Amos H. Enhancement of hexose entry into chick fibroblasts by starvation Differential effect on galactose and glucose . Proc. Natl. Acad. Sci. U. S. A. 69:1972;3407-3411.
28. Minn H., Clavo A. C., Wahl R. L. Influence of hypoxia on tracer accumulation in squamous cell carcinoma In vitro evaluation for PET imaging . Nucl. Med. Biol. 23:1996;941-946.
29. Monakhov N. K., Neistadt E. L., Shavlovskii M. M., Shartsman A. L., Neifakh S. A. Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J. Natl. Cancer Inst. 61:1978;27-33.
30. Mueckler M., Caruso C., Baldwin S. A., Panico M., Allard W. J., Lienhard G. E., Lodish H. Sequence and structure of a human glucose transporter. Science. 229:1985;941-945.
31. Mueckler M., Holman G. Homeostasis without a GLUT. Nature. 377:1995;100-101.
32. Murakami T., Nishiyama T., Shirotani T., Shinohara Y., Kan M., Ishii K., Kanai F., Nakazuru F., Ebina Y. Type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes. J. Biol. Chem. 267:1992;9300-9306.
33. Nishioka T., Oda Y., Seino Y., Yamamoto T., Inagaki N., Yano H., Imura H., Shigemoto R., Kikuchi H. Distribution of glucose transporters in human brain tumors. Cancer Res. 52:1992;3972-3979.
34. 18F]Fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain . Radiology. 144:1982;885-889.
35. Phelps M. E., Huang S. C., Hoffman E. J., Selin C., Sokoloff L., Kuhl D. E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxy-D-glucose Validation of method . Ann. Neurol. 6:1979;371-388.
36. Pulselli R., Amadio L., Fanciulli M., Floridi A. Effect of lonidamine on the mitochondrial potential in situ in Ehrlich ascites tumor cells. Anticancer Res. 16:1996;419-423.
37. 11C]deoxyglucose . J. Cereb. Blood Flow Metab. 5:1985;179-192.
38. Rigo P., Paulus P., Kaschten B. J., Hustinx R., Bury T., Jerusalem G., Benoit T., Foidart-Willems J. Oncological applications of positron emmission tomography with fluorine-18 fluorodeoxyglucose. Eur. J. Nucl. Med. 23:1996;1641-1674.
39. Ruoslahti E., Reed J. C. Anchorage dependence, integrins and apoptosis. Cell. 77:1994;477-478.
40. Scheffzek K., Ahmadian M. R., Kabsch W., Wiesmüller L., Lautwein A., Schmitz F., Wittinghofer A. The ras-rasGAP complex Structural basis for GTPase activation and its loss in oncogenic ras mutants . Science. 277:1997;333-338.
41. Schmidt K. C., Lucignani G., Sokoloff L. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilisation A re-examination . J. Nucl. Med. 37:1996;394-399.
42. Schuier F., Orzi F., Suda S., Lucignani G., Kennedy C., Sokoloff L. Influence of plasma glucose concentration on lumped constant of the deoxyglucose method Effects of hyperglycemia in the rat . J. Cereb. Blood Flow Metab. 10:1990;765-773.
43. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M. H., Patlak C. S., Pettygrew K. D., Sakurada O., Shinohara M. The [14-C]deoxyglucose method for the measurement of local cerebral glucose utilisation Theory, procedure, and normal values in the conscious and anesthetized albino rat . J. Neurochem. 28:1977;897-916.
44. Som P., Atkins H. L., Bandoypadhyay D., Fowler J. S., MacGregor R. R., Matsui K., Oster Z. H., Sacker D. F., Shiue C. Y., Turner H., Wan C.-N., Zabinski S. V. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18) Nontoxic tracer for rapid tumor detection . J. Nucl. Med. 21:1980;670-675.
45. Strauss L. G. Fluorine-18 deoxyglucose and false-positive results A major problem in the diagnostics of oncological patients . Eur. J. Nucl. Med. 23:1996;1409-1415.
46. Su T.-S., Tsai T.-F., Chi C.-W., Han S.-H., Chou C.-K. Elevation of facilitated glucose transporter messenger RNA in human hepatocellular carcinoma. Hepatology. 11:1990;118-122.
47. Wahl R. L., Cody R. L., Hutchins G. D., Mudgett E. E. Primary and metastatic breast carcinoma Initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose . Radiology. 179:1991;765-770.
48. Warburg O. Uber den Stoffwechsel der Carcinomzelle. Klin. Wochenschr. Berl. 4:1925;534-536.
49. Warburg O. On the origin of cancer cells. Science. 123:1956;309-314.
50. Weber G. Enzymology of cancer cells (first of two parts). N. Engl. J. Med. 296:1977;486-492.
51. Weber G. Enzymology of cancer cells (second of two parts). N. Engl. J. Med. 296:1977;541-551.
52. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., G. M. Identification of the breast cancer susceptibility gene BRCA2. Nature. 378:1995;789-792.
53. Yamamoto T., Seino Y., Fukumoto H., Koh G., Yano H., Inagaki N., Yamada Y., Inoue K., Manabe T., Imura H. Over-expression of facilitative glucose transporter genes in human cancer. Biochem. Biophys. Res. Commun. 170:1990;223-230.
54. Yonekura Y., Benua R. S., Brill A. B., Som P., Yeh S. D. J., Kemeny N. E., Fowler J. S., MacGregor R. R., Stamm R., Christman D. R., Wolf A. P. Increased accumulation of 2-deoxy-2-[18F]-fluoro-D-glucose in liver metastases from colon carcinoma. J. Nucl. Med. 23:1982;1133-1137.